Ultrasound joint health in hemophilia A patients on emicizumab
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study uses ultrasound to check if joints that are currently healthy stay healthy in people with hemophilia A who are taking emicizumab (Hemlibra) as their regular treatment. It aims to see if this treatment helps prevent joint damage over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have hemophilia A.
- You are currently taking emicizumab (Hemlibra) as your regular treatment.
- You are at least 10 years old.
- At least one of your elbows, knees, or ankles has no joint damage as seen on an ultrasound at the start of the study.
- You have not had any bleeding into those joints since starting emicizumab.
- You can understand and complete the study procedures, and if you are a minor, your parent or guardian can give consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an educational program to help people with hemophilia manage chronic joint pain better. Participants will learn pain management skills that may improve daily comfort and quality of life.
This study uses MRI scans to look at the knee joints of adults with hemophilia who have had repeated knee bleeds. It aims to understand how the joint is affected, which could help guide better care.
This study tests whether special knee-strengthening exercises using a machine can improve how well boys with hemophilia can use their affected knee. The goal is to see if these exercises help with daily activities and reduce joint problems.
This study looks at chronic pain in people with severe hemophilia A. It aims to understand pain better through questionnaires and joint health checks.
This study uses ultrasound to check the health of your joints. It aims to see if people with mild hemophilia have joint problems even without frequent bleeding, which could help guide future treatment.
This study uses ultrasound to check if thickened joint lining (synovium) in people with severe hemophilia is a sign of active inflammation or just a harmless leftover. It may help doctors decide whether to treat or watch these joints.
Hear when a new Hemophilia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.